Menu Close

Author: WorkCompAcademy

Bay Area Pain Doctors Pay $260K to Resolve DEA Charges

Drs. William Longton, Ruben Kalra, and Richard Shinaman have agreed to collectively pay $260,000 to settle allegations by the U.S. Department of Justice that they failed to keep and maintain adequate records and other allegations pertaining to controlled substances at their Novato, Pleasant Hill, and Pleasanton offices.

The physicians operate under the name Pain Medicine Consultants, Inc., with offices in multiple Bay Area locations.

The settlement agreement resolves allegations by the government that a January 2014 DEA inspection uncovered multiple violations by Longton, Kalra, and Shinaman of the Controlled Substances Act, 21 U.S.C. § 801.

In the agreement, the physicians acknowledge that they each, at the relevant time, were registered with the DEA as Practitioners, providing them with authorizations to handle Schedules II through V controlled substances. They also acknowledge they had an obligation to “keep and maintain” records related to their receipt and distribution of controlled substances in connection with their practices.

According to the agreement, following the DEA’s inspection, the government concluded that between January 10, 2012, through January 17, 2014, Shinaman, Longton, and Kalra failed to keep and maintain adequate records pertaining to controlled substances, as required by 21 C.F.R. § 1304, et seq.; failed to include the address of the patient on controlled substance prescriptions that they each issued as required by 21 C.F.R. § 1306.05(a); and exceeded the authority of their registrations by filling a prescription for a controlled substance, in violation of 21 C.F.R. § 1306.06.

According to the terms of the agreement, Longton, Kalra, and Shinaman will collectively pay the government $260,000 to resolve all civil claims related to the violations identified in the investigation.

Assistant U.S. Attorney Rebecca A. Falk is handling the matter on behalf of the U.S. Attorney’s Office for the Northern District of California, with assistance from the DEA San Francisco Field Division, Oakland Resident Office Diversion Group.

Anthem SIU Investigator Charged in $20M Fraud Scheme

Five people linked to two San Fernando Valley clinics were arrested on federal health care fraud charges for allegedly participating in a scheme that submitted fraudulent claims to health insurance companies. A federal grand jury indictment alleges that the five defendants – including a former fraud investigator at Anthem Blue Cross – engaged in a multi-year conspiracy to commit health care fraud against at least eight health insurance companies.

Those arrested include the owner and operator of the clinics, Roshanak Khadem, also known as “Roxanne” and “Roxy” Khadem, 50, of Sherman Oaks. Khadem owned and operated the two clinics at the center of the alleged scheme – R&R Med Spa, which was located in Valley Village until early 2016, and its successor company, Nu-Me Aesthetic and Anti-Aging Center, which operated in Woodland Hills.

The indictment alleges that Khadem and others induced patients to visit the clinics to receive free cosmetic procedures – including facials, laser hair removal and Botox injections – which were not covered by insurance. The conspirators obtained the insurance information from the patients and fraudulently billed insurance companies for unnecessary medical services or for services that were never provided. Using the fraudulent proceeds from the insurance companies, Khadem and other conspirators calculated a “credit” that patients could use to receive “free” or discounted cosmetic procedures.

During the course of the conspiracy, Khadem and her conspirators allegedly submitted at least $20 million in claims to the insurance companies, which paid approximately $8 million on those claims, according to the indictment.

The other four defendants who were arrested are:

– Dr. Roberto Mariano, 59, of Rancho Cucamonga, a physician who helped operate the clinics;

– Marina Sarkisyan, 49, of Panorama City, who was the office manager at the clinics;

– Lucine Ilangezyan, 38, of North Hills, an employee and insurance biller for the clinics; and

– Gary Jizmejian, 44, of Santa Clarita, a former senior investigator at the Anthem Special Investigations Unit, the anti-fraud unit within Anthem that is responsible for investigating health care fraud committed against the insurance company.

The indictment alleges that, in return for cash payments, Jizmejian assisted Khadem and others by providing them with confidential Anthem information that helped them submit fraudulent bills to Anthem. In September 2012, Jizmejian gave Khadem insurance billing codes – CPT Codes – that Jizmejian knew could be used to submit fraudulent claims to Anthem without Anthem detecting the fraudulent claims. Jizmejian gave Khadem the billing code for an allergy-related lab test and instructed her to submit to Anthem large numbers of bills with this CPT code. Khadem and other members of the conspiracy used this billing code to submit approximately $1 million in fraudulent claims to Anthem, according to the indictment.

The indictment further alleges that Jizmejian worked to prevent the insurance companies from detecting the fraud at the clinics, which included helping Khadem to avoid responding to inquiries from fraud investigators, diverting attention of other Anthem SIU investigators away from the clinics, and closing Anthem investigations into fraud that was being committed at the clinics.

In September 2015, based on confidential information obtained from Anthem, Jizmejian tipped Khadem off about a federal criminal investigation into the clinics, according to the indictment.

The scheme involving the two clinics allegedly defrauded the International Longshore and Warehouse Union, Pacific Maritime Association Benefit Plan, which is the health benefit plan that covers longshore workers in Southern California and their dependents, according to the indictment. Another victim was the Federal Employees Health Benefits Program, which provides health insurance for federal employees.

Known Undocumented Workers Prevail on Wage and Hour Claim

The California Court of Appeal affirmed the rule that after discovery of undocumented worker status by an employer, the workers are entitled to most of the legal rights and remedies provided to employees by state and federal laws. This includes wage and hour laws.

Juan Luis Lepe, Virgilio Flores-Juarez, and Berna Vargas filed a lawsuit against their former employer, Luft Enterprises, a California Corporation, doing business as Inn-Decor and Otmar Luft, alleging unpaid overtime wages, failure to provide meal and rest periods, and other Labor Code violations and unfair business practices

The Company manufactures furniture for businesses such as restaurants and casinos. Plaintiffs worked 10 or more hours per day without an afternoon or second meal break. The Company failed to pay overtime wages or provide meal and rest periods. Prior to May 2010, defendants were aware that plaintiffs were not authorized to work in the United States due to their immigration status. This was the agreed upon claim period in this case.

The trial court entered judgment in favor of plaintiffs in the total amount of $140,016 (Lepe – $59,776; Flores-Juarez -$59,776; and Vargas – $20,464) and against all defendants jointly and severally. Plaintiffs were also awarded their attorney’s fees and costs.

Defendants appealed and challenge the judgment, contending (1) they may not be compelled, as a matter of law, to pay past wages allegedly due because plaintiffs were not legally authorized to work in the United States; (2) there is insufficient evidence that defendants issued inaccurate wage statements; (3) the trial court erroneously granted plaintiffs’ attorney’s fees motion; and (4) the trial court abused its discretion in awarding certain costs.

The Court of Appeal found merit in defendants’ challenge to the award of costs but otherwise affirmed in the unpublished case of Lepe v. Luft Enterprises, Calif. Ct. App., No. E067382 (May 10, 2018).

In support of their contention, defendants rely on the holding in Salas v. Sierra Chemical Co. (2014) 59 Cal.4th 407, 414, 424-425 (Salas). The Court of Appeal found such reliance to be misplaced.

In Salas, the plaintiff sued his former employer under the California Fair Employment and Housing Act (FEHA) alleging defendant employer failed to reasonably accommodate his physical disability and refused to rehire him in retaliation for filing a worker’s compensation claim. After the complaint was filed in Salas, the defendant learned that the plaintiff may have used another man’s Social Security number in order to gain employment. Defendant successfully moved for summary judgment.

The California Supreme Court reversed, holding that the federal Immigration Reform and Control Act of 1986 (8 U.S.C. § 1101 et seq.) did not preempt application of the antidiscrimination provisions of California’s FEHA to workers who are unauthorized aliens, but that “federal preemption does bar an award of lost pay damages under the FEHA for any period of time after an employer’s discovery of the employee’s ineligibility under federal law to work in the United States.”

In reaching this holding, the Salas court noted that its “preemption analysis for the postdiscovery period is limited to employers who discover the plaintiff employee’s unauthorized status after the employee has been discharged or not rehired. . . . Because imposing full liability for lost wages would provide a disincentive for such immigration law violations, thereby furthering the goals of federal immigration law, in these situations arguably federal law would not preempt lost wages remedies for violations of state laws like California’s FEHA.”

Here, defendants concede knowledge of plaintiffs’ unauthorized work status during the “agreed-upon claim period in this case.”

“Since defendants were aware of plaintiffs’ unauthorized work status during the time of their employment, defendants actively joined in the violation of federal immigration law. Under this circumstance, the Salas court holding does not apply, and plaintiffs are not barred from recovering their lost wages.”

CDI Criticizes Carriers for Excessive Comp Premiums

Insurance Commissioner Jones adopted and issued a revised workers’ compensation insurance advisory pure premium rate, lowering the benchmark to $1.74 per $100 of payroll for workers’ compensation insurance, effective July 1, 2018.

Jones has reduced the benchmark rate by 36.5 percent since January 2015, when the average pure premium rate was $2.74 per $100 of payroll.

With an average filed pure premium rate of $2.22 per $100 of payroll as of January 1, 2018, insurers are on average applying pure premium rates that are 27.6 percent more than the indicated pure premium rate approved by the Commissioner today. Even after considering the industry’s extensive use of rating plan credits, industry profitability appears to be substantial as a percentage of premium.

“It is time insurers do the right thing and pass along more cost savings to California employers who deserve to share in the benefits cost reductions have brought to the workers’ compensation system,” said Insurance Commissioner Jones. “In addition to the cost reductions that have led to higher profits, insurers are also benefiting from the federal income tax break, which should result on average in about another five percent decrease in premiums.”

Commissioner Jones’ order sets the advisory pure premium rate below the $1.80 average rate recommended by the Workers’ Compensation Insurance Rating Bureau (WCIRB) in its filing. Jones issued the advisory rate after a public hearing and careful review of the testimony and evidence submitted by stakeholders.

The pure premium benchmark rate is only advisory, as the Legislature has not given the insurance commissioner authority over workers’ compensation insurers’ rates.

The purpose of the pure premium benchmark rate process is to review costs in the workers’ compensation insurance system and to confirm that rates filed by insurance companies are adequate to cover benefits for injured workers and to provide information to employers, workers and the public about the cost trends in the system.

The WCIRB’s pure premium advisory rate filing established that overall costs continue to decline in California’s workers’ compensation insurance system. The pure premium advisory rate reduction is based on insurers’ cost data through December 31,2017. Insurers’ net costs in the workers’ compensation system continue to decline as a result of SB 863, SB 1160, and AB 1244 enacted by the

Legislature and Governor Brown. The WCIRB noted continued favorable medical loss development including acceleration in claim settlements.

Federal Right to Try Drug Law Moves to Senate

The U.S. House of Representatives passed “right to try” legislation that would allow people with life-threatening illnesses to bypass the Food and Drug Administration to obtain experimental medications, ending a drawn-out battle over access to unapproved therapies.

Now the legislation needs approval from the Senate. If so, President Trump is expected to quickly sign the measure, which was praised by supporters as a lifeline for desperate patients but denounced by scores of medical and consumer groups as unnecessary and dangerous.

The FDA would be largely left out of the equation under the new legislation and would not oversee the right-to-try process.  Drug manufacturers would have to report “adverse events” — safety problems, including premature deaths — only once a year. The agency also would be restricted in how it used such information when considering the experimental treatments for approval.

Patients would be eligible for right-to-try if they had a “life-threatening illness” and had exhausted all available treatment options. The medication itself must have completed early-stage safety testing, called Phase 1 trials, and be in active development with the goal of FDA approval.

One Congressman opposing the bill argued that eliminating FDA oversight would “provide fly-by-night physicians and clinics the opportunity to peddle false hope and ineffective drugs to desperate patients,” noting that the bill is opposed by over 100 patient advocacy and consumer groups.

Right-to-try laws exist in 40 states — including California. But this federal bill would introduce legislation across state lines. Right To Try was signed into law in California (Assembly Bill No. 1668) by Governor Jerry Brown on September 27, 2016. It allows very sick patients to plea for experimental treatments directly from drug companies, instead of waiting for years for drugs to hit the market or asking the Food and Drug Administration for early access.

But patients and advocates said the California law does not function well without a federal counterpart. As it stands, if someone experiences adverse effects while taking a drug acquired through California’s Right to Try policy, the FDA can pull the treatment from the clinical trial process. The mismatch has made drug companies reluctant to participate.

The federal right to try law would make California law more effective, or eliminate the need for the California law altogether

Pfizer to Pay $23.8M to Resolve Kickback Claim

The Justice Department announced that pharmaceutical company Pfizer, Inc. has agreed to pay $23.85 million to resolve claims that it used a charitable foundation as a conduit to pay the copays of Medicare patients taking three Pfizer drugs.

Under the Anti-Kickback Statute, a pharmaceutical company is prohibited from offering, directly or indirectly, any remuneration – which includes paying patients’ copay obligations – to induce Medicare patients to purchase the company’s drugs.

The government alleged that Pfizer used a foundation as a conduit to pay the copay obligations of Medicare patients taking three Pfizer drugs: Sutent and Inlyta, which both treat renal cell carcinoma, and Tikosyn, which treats arrhythmia in patients with atrial fibrillation or atrial flutter.

The government alleged that, in order to generate revenue, and instead of giving Sutent and Inlyta to Medicare patients who met the financial qualifications of Pfizer’s existing free drug program, Pfizer used a third-party specialty pharmacy to transition certain patients to the foundation, which covered the patients’ Medicare copays. Pfizer allegedly made donations to the foundation to enable it to cover the copays of these patients and received confirmation from the foundation, via the specialty pharmacy, that the foundation funded the copays.

With respect to Tikosyn, Pfizer raised the wholesale acquisition cost of a package of forty .125 mg capsules of the drug by over 40 percent in the last three months of 2015. Pfizer allegedly knew that the price increase would also increase Medicare beneficiaries’ copay obligations for Tikosyn, and potentially prevent some patients from being able to afford the drug. Pfizer allegedly worked with the foundation to create and finance a fund for Medicare patients suffering from the condition treated by Tikosyn, coordinated the opening of the fund with the implementation of its price increase for the drug, and referred patients to the fund. For the next nine months, Tikosyn patients accounted for virtually all of the beneficiaries whose copayments were paid by the fund.

Pfizer has also entered into a corporate integrity agreement with the Department of Health and Human Services Office of Inspector General (HHS-OIG).

The five-year CIA requires, among other things, that Pfizer implement measures designed to ensure that arrangements and interactions with third-party patient assistance programs are compliant with the law. In addition, the CIA requires reviews by an independent review organization, compliance-related certifications from company executives and Board members, and the implementation of a risk assessment and mitigation process.

The investigation was conducted by the Justice Department’s Civil Division and the U.S. Attorney’s Office for the District of Massachusetts, in conjunction with the Department of Health and Human Services, Office of Inspector General; the Federal Bureau of Investigation: the Department of Veterans Affairs, Office of Inspector General; and the United States Postal Inspection Service.

State Bar Adopts 69 New Rules of Professional Conduct

This month, the California Supreme Court issued an order approving 69 new Rules of Professional Conduct, which will go into effect for California attorneys on Nov. 1, 2018. The current rules remain in effect until then.

The court approved 27 amended rules as a state bar committee submitted them. Justices modified and authorized 42 more. And they rejected entirely one proposed rule on a lawyer’s obligations to clients “with diminished capacity”

The California Rules of Professional Conduct are intended to regulate professional conduct of attorneys licensed by the State Bar through discipline. They have been adopted by the Board of Trustees and approved by the California Supreme Court pursuant to statute to protect the public and to promote respect and confidence in the legal profession. The rules and any related standards adopted by the Board are binding on all members of the State Bar.

The new rules are the first comprehensive changes to the rulebook in 29 years. The ethical roadmap for California’s 250,000 attorneys covers 112 pages. It was approved by all seven justices. Here are five things lawyers should know about the new rules according to the summary on law.com.

➤➤ Conflict of interest rules are broader and less case-specific. For example, a new definition of what constitutes a legal “matter” covered by conflict disclosure and non-representation requirements is more expansive now. The changes are much more conforming and much more inclusive of how lawyers nationally understand conflicts of interest.

➤➤ Prohibitions on harassment, discrimination and retaliation by lawyers, both in the workplace and in the practice of law, have been expanded. The rule, the subject of intense debate during drafting, requires “all law firm lawyers the responsibility to advocate corrective action to address known harassing or discriminatory conduct by the firm or any of its lawyers or nonlawyer personnel.”

The state bar can now open an investigation into alleged harassment or discrimination without a triggering civil finding by another agency. Lawyers who receive a related disciplinary charge from the bar will be required to notify state and federal workplace-fairness agencies. One observer said “It’s frankly as broad as about any rule in the country.”

➤➤ The rules don’t specifically mention lawyers serving clients in the marijuana industry. The rules-writing committee sent the Supreme Court a proposed rule “Rule 1.2.1” that would allow lawyers to “discuss the legal consequences of any proposed course of conduct with a client” so long as they don’t counsel that client to break the law. Tuft said the high court sent the rule back about a month ago for more work on some accompanying comments but not the language of the rule itself. Tuft said the rule should be applicable to various topics, such as immigration, where federal and state laws conflict.

➤➤ In most cases, lawyers can’t have sexual contact with their clients. This rule has received a lot of public attention. Currently, the rules bar lawyers from having sex with clients if the act is coerced or considered a form of payment for services rendered. The new rule forbids lawyer-client sex unless there was a previous consensual relationship.

➤➤ The court nixed a rule laying out a lawyer’s responsibilities in representing clients with “diminished capacities.” The justices did not explain the deletion, although they may have decided language dealing with client confidentiality and privacy may have stepped too far into the Legislature’s purview. The California Lawyers Association’s trusts and estates section had sought more clarity in the rules for attorneys practicing in this field.

Attorneys have about six months to become familiar with the rest of the 69 new rules. Ethics is a mandated continuing education topic, and this MCLE cycle will no doubt cover these new rules.

Appellate Court Affirms Correctional Officer Fraud Conviction

Hosea Morgan worked at San Quentin State Prison as a correctional officer and correctional counselor. He filed two claims with the State Fund for multiple disabling workplace injuries. State Fund paid a total of $74,619.13 in workers’ compensation benefits.

Surveillance by investigators revealed that while on leave, he engaged in physical activities that were inconsistent with his claimed injuries, including basketball, theater, lifting appliances, and long walks. His PTP said he would not have taken appellant off work if he had known he was able to play basketball.

His PQME was shown the surveillance video at trial, and said that Morgan had not disclosed his true physical condition and should have returned to work during the period he was placed on disability leave.

Morgan’s defense at his criminal trial was that his claims were legitimate and that although he engaged in the physical activities captured on the surveillance tapes, he was in pain when he did so.

A jury convicted him of five felony counts arising from a fraudulent workers’ compensation claim: insurance fraud in violation of Penal Code section 550, subdivision (b)(1), insurance fraud in violation of Insurance Code section 1871.4, subdivision (a)(1), grand theft of personal property in violation of Penal Code section 487, subdivision (a), presentation of a fraudulent claim in violation of Penal Code section 72, and perjury in violation of Penal Code section 118. The conviction was affirmed in the unpublished case of People v Hosea Morgan.

Morgan argued on appeal that he suffered unfair prejudice based on the combined effect of two pieces of evidence: (1) a surveillance video that showed him walking down a pier kissing a woman who was not his wife; and (2) his unsuccessful attempt to recover workers’ compensation benefits for erectile dysfunction. He argued that this evidence had little, if any, probative value and was clearly prejudicial.

The prosecutor sought to introduce evidence that appellant walked about half a mile down the Vallejo pier, which contradicted his statements to investigators that his injuries limited his ability to walk. And the woman in the tape was not be identified. And the tape was redacted to edit out a prolonged embrace between appellant and the woman.

The opinion concluded that the “trial court did not act in an arbitrary, capricious or patently absurd manner by admitting the redacted tape or the evidence of erectile dysfunction. There was no abuse of discretion.”

Morgan’s attempt to obtain workers’ compensation benefits for erectile dysfunction when there was evidence it was in fact unrelated to his industrial injury tended to show that he was untruthful in making his other workers’ compensation claims for which benefits were paid. “Where fraud is charged, evidence of other frauds or fraudulent representations of like character, committed by the same parties at or near the same time is admissible to prove intent.”

More Names Placed on DWC Suspension List

The Division of Workers’ Compensation has suspended three more medical providers from participating in California’s workers’ compensation system, bringing the total number of providers suspended to 245.

The most well know on the new list is Ronald Grusd MD who was convicted in federal court in 2017 for his involvement in a complex illegal referral scheme with suspended providers Steven Rigler, Carlos Arguello, Fermin Iglesias and Alexander Kiev Martinez to defraud the California workers’ compensation system by recruiting patients, paying illegal referral fees, and fraudulently submitting misleading documentation to insurers.

Beverly Hills Radiologist Ronald Grusd and two of his corporations, California Imaging Network Medical Group and Willows Consulting Company, were convicted by a federal jury of fraud and bribery charges in connection with a massive health care-fraud scheme.

After a seven-day trial, the jury found Grusd and his companies guilty on all charges facing them, including Conspiracy, Honest Services Mail and Wire Fraud, Health Care Fraud, and Travel Act violations, based on their years-long bribery and fraud scheme.

According to evidence presented at trial, Dr. Grusd and his companies paid kickbacks for patient referrals from multiple clinics in San Diego and Imperial counties in order to fraudulently bill insurance companies over $25 million for medical services. Dr. Grusd negotiated with various individuals, including a primary treating physician, the payment of kickbacks for the referral of workers’ compensation patients for various medical services, including MRIs, ultrasounds, Shockwave treatments, toxicology testing and prescription pain medications.

After the patients were referred for the treatment or service, one of Dr. Grusd’s companies, California Imaging Network Medical Group, would fraudulently bill insurance companies for the procedures, concealing from both the patients and the insurers that substantial kickbacks had been paid in violation of California law. Another of Dr. Grusd’s companies, Willows Consulting Company, funneled the kickback payments to those directing the referral of the patients from the various clinics. Records presented at trial showed that Dr. Grusd paid over one hundred thousand dollars in bribes to secure the billings for hundreds of patients, with bribes paid on a per-patient or per-body-part formula.

Grusd and the corporations were originally indicted by a federal grand jury in November 2015, when the U.S. Attorney’s Office and the San Diego District Attorney’s Office, working in conjunction with the Federal Bureau of Investigation and the California Department of Insurance, announced multiple arrests arising from “Operation Back Lash” – a long-term, proactive health care fraud investigation targeting corruption and fraud in the California Workers’ Compensation system that is continuing.

Grusd’s practice, California Imaging Network Medical Group, operated clinics throughout California in San Diego, Los Angeles, Beverly Hills, Fresno, Rialto, Santa Ana, Studio City, Bakersfield, Calexico, East Los Angeles, Lancaster, Victorville and Visalia.

Also on the new suspension list is Toros Yeranosian of Encino, co-owner of Mauran Ambulance Service, and Aharon Krkasharyan of Los Angeles, manager of Mauran, were convicted in federal court in 2017 of conspiracy to commit healthcare fraud for their involvement in an illegal scheme of providing unnecessary ambulance transportation services to Medicare beneficiaries and creating fraudulent reasons that justified the services. Yeranosian, Krkasharyan and their co-conspirators submitted over $1 million in false and fraudulent claims to Medicare.

Reserving for a Lifetime Award – a Moving Target

One of the many important workers’ compensation claims administration tasks is to place accurate reserves for future claims costs, especially in claims that will be open for the life of the claimant.

Life expectancy increased each year for several decades, giving rise to higher reserves for lifetime awards. That trend seems to have reversed.

The U.S. death rate rose last year, and 2017 likely will mark the third straight year of decline in American life expectancy, according to preliminary data published by the National Center for Health Statistics.

Provisional estimates are based on a snapshot of all the vital statistics data received and processed by NCHS as of a specified cutoff date. To adjust for the incompleteness of these data, individual records are weighted to independent provisional counts of all the deaths that occurred in each state by month.

In this release of Quarterly Provisional Estimates, NCHS presents provisional estimates of death rates for the fourth quarter of 2017. Reliable estimates for the most recent quarters may not be available for some causes of death. The estimates are based on all death records received and processed by NCHS as of April 15, 2018. Estimates are presented for 15 leading causes of death plus estimates for deaths attributed to drug overdose, falls for persons aged 65 and over, firearm-related deaths, human immunodeficiency virus (HIV) disease, and homicide.

Death rates rose for Alzheimer’s disease, diabetes, flu and pneumonia, and three other leading causes of death, according to numbers posted online.

Full-year data is not yet available for drug overdoses, suicides or firearm deaths. But partial-year statistics in those categories showed continuing increases.

Just as important, there was little change in the death rate from the nation’s No. 1 killer: heart disease. In the past, steady annual drops in heart disease death rates offset increases in other causes. But that offset is no longer happening, experts say.

For decades, life expectancy increased, rising a few months nearly every year. But 2016 was the second year in a row in U.S. life expectancy fell, a rare event that had occurred only twice before in the last century.

There was some good news.The death rate for cancer, the nation’s No. 2 killer, continued to drop. It fell 2 percent from 2016. Death rates from HIV and blood infections also declined. The heart disease death rate fell too, but only by 0.3 percent. Experts think the nation’s increasing obesity rate is probably a factor in the flattening of heart disease death rates.

A more complete report is expected around the end of the year.